Literature DB >> 11822498

Stressors and coping methods among chronic haemodialysis patients in Hong Kong.

E Mok1, B Tam.   

Abstract

The purpose of the study was to determine the stressors and coping methods of chronic haemodialysis patients in Hong Kong. Relationships among treatment-related stressors, coping methods and length of time on haemodialysis were explored. Fifty subjects completed the Haemodialysis Stressor Scale (HSS) and Jalowiec Coping Scale (JCS). Results revealed that limitation of fluid was the most frequently identified stressor, followed by limitation of food, itching, fatigue and cost. The most common coping methods are 'accepted the situation because very little could be done', followed by 'told oneself not to worry because everything would work out fine' and 'told oneself that the problem was really not that important.' It was found that the traditional philosophies of the Chinese--Confucianism, Buddhism, and Taoism--share an approach to the understanding and management of life stressors as different from that adopted by Western philosophies. The findings of this study can further facilitate nurse practitioners in providing support, information, and alternative solutions when assisting patients in coping with long-term haemodialysis.

Entities:  

Mesh:

Year:  2001        PMID: 11822498     DOI: 10.1046/j.1365-2702.2001.00500.x

Source DB:  PubMed          Journal:  J Clin Nurs        ISSN: 0962-1067            Impact factor:   3.036


  14 in total

1.  Quality of life and psychosocial factors in African Americans with hypertensive chronic kidney disease.

Authors:  Anna Porter; Michael J Fischer; Deborah Brooks; Marino Bruce; Jeanne Charleston; William H Cleveland; Donna Dowie; Marquetta Faulkner; Jennifer Gassman; Tom Greene; Leena Hiremath; Cindy Kendrick; John W Kusek; Denyse Thornley-Brown; Xuelei Wang; Keith Norris; Mark Unruh; James Lash
Journal:  Transl Res       Date:  2011-10-12       Impact factor: 7.012

2.  Factors Affecting Quality of Life in Patients Receiving Hemodialysis.

Authors:  Kyung A Lim; Jin Hee Lee
Journal:  Iran J Public Health       Date:  2022-02       Impact factor: 1.479

3.  The experience and self-management of fatigue in patients on hemodialysis.

Authors:  Ann E Horigan; Susan M Schneider; Sharron Docherty; Julie Barroso
Journal:  Nephrol Nurs J       Date:  2013 Mar-Apr       Impact factor: 0.959

4.  Influence of Selected Biomarkers on Stress and Alexithymia in Patients Under Hemodialysis Treatment.

Authors:  Esra Tayaz; Ayşegül Koç
Journal:  Yonago Acta Med       Date:  2019-11-22       Impact factor: 1.641

5.  Determinants of compliance behaviours among patients undergoing hemodialysis in Malaysia.

Authors:  Yoke Mun Chan; Mohd Shariff Zalilah; Sing Ziunn Hii
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

6.  Roy's Adaptation Model-Based Patient Education for Promoting the Adaptation of Hemodialysis Patients.

Authors:  Ardashir Afrasiabifar; Zohreh Karimi; Parkhideh Hassani
Journal:  Iran Red Crescent Med J       Date:  2013-07-05       Impact factor: 0.611

7.  Quality of life in dialysis patients from the United Arab Emirates.

Authors:  Abdelbasit M Ayoub; Kamal H Hijjazi
Journal:  J Family Community Med       Date:  2013-05

8.  Physiological and psychosocial stressors among hemodialysis patients in educational hospitals of northern iran.

Authors:  Mohammad Ali Heidari Gorji; Ali Mahdavi; Yadollah Janati; Ehteramossadat Illayi; Jamshid Yazdani; Javad Setareh; Seyed Azam Hoseiny Panjaki; Ali Morad Heidari Gorji
Journal:  Indian J Palliat Care       Date:  2013-09

Review 9.  An integrative review of the methodology and findings regarding dietary adherence in end stage kidney disease.

Authors:  Kelly Lambert; Judy Mullan; Kylie Mansfield
Journal:  BMC Nephrol       Date:  2017-10-23       Impact factor: 2.388

Review 10.  Phosphate-control adherence in hemodialysis patients: current perspectives.

Authors:  Ebele M Umeukeje; Amanda S Mixon; Kerri L Cavanaugh
Journal:  Patient Prefer Adherence       Date:  2018-07-04       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.